세계의 C반응성 단백질 검사 시장 : 산업 규모, 점유율, 동향, 기회 및 예측 - 어세이 유형별, 감지 범위별, 질환 영역별, 최종 이용 산업별, 지역별, 경쟁별(2020-2030년)
C-reactive Protein Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Assay Type, By Detection Range, By Disease Area, By End-Use Industry, By Region & Competition, 2020-2030F
세계 C 반응성 단백질(CRP) 시장은 2024년 16억 8,020만 달러에 달했으며, 2030년까지 연평균 2.10%의 꾸준한 성장이 예상됩니다.
CRP 검사는 널리 사용되는 검사실 진단 도구로, 혈액 내 C 반응성 단백질(간에서 생성되는 염증성 바이오마커)의 농도를 측정합니다. 이 검사는 감염, 부상, 만성 질환에 대한 신체의 염증 반응을 평가하는 데 도움이 됩니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
16억 8,020만 달러 |
| 시장 규모 : 2030년 |
19억 791만 달러 |
| CAGR : 2025-2030년 |
2.10% |
| 급성장 부문 |
면역 비탁도 분석 |
| 최대 시장 |
북미 |
의료 전문가들은 감염, 자가면역질환, 심혈관질환, 수술 후 합병증 등 다양한 질환의 진단 및 모니터링에 CRP 검사를 자주 사용합니다. 검사 결과는 리터당 밀리그램(mg/L) 단위로 보고되며, 염증의 심각성 및 진행 정도에 대한 귀중한 정보를 제공하여 적시에 진단 및 질병 관리 전략을 지원합니다.
주요 시장 성장 촉진요인
염증성 질환 및 감염성 질환의 유병률 증가
주요 시장 과제
CRP 수치 상승에 대한 특이성 부족
주요 시장 동향
개인 맞춤형 의료의 중요성 증대
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 C반응성 단백질 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 어세이 유형별(면역비탁법, ELISA, 화학 발광 면역측정법, 기타)
- 감지 범위별(hs-CRP, 기존 CRP, cCRP)
- 질환 영역별(심혈관 질환, 암, 류마티스 관절염, 염증성 장질환, 자궁내막증, 낭창, 기타)
- 최종 이용 산업별(병원 및 진료소, 연구소, 간호 의료시설, 홈케어, 기타)
- 지역별
- 기업별(2024년)
- 시장 맵
제6장 북미의 C반응성 단백질 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 C반응성 단백질 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 C반응성 단백질 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 C반응성 단백질 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 C반응성 단백질 검사 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
제11장 시장 역학
제12장 시장 동향과 발전
제13장 세계의 C반응성 단백질 검사 시장 : SWOT 분석
제14장 경쟁 구도
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corp
- Quest Diagnostics
- Siemens Healthineers AG
- Abbott Laboratories Inc.
- Merck KGaAA
- Zoetis Inc.
- Ortho Clinical Diagnostics
- Getein Biotech, Inc.
제15장 전략적 제안
제16장 회사 소개 및 면책조항
LSH
Global C-reactive protein (CRP) testing market was valued at USD 1,680.20 million in 2024 and is expected to witness steady growth, with a projected compound annual growth rate (CAGR) of 2.10% through 2030. CRP testing is a widely utilized laboratory diagnostic tool that measures the concentration of C-reactive protein-a liver-produced biomarker indicative of inflammation-in the blood. This test is instrumental in evaluating the body's inflammatory response to infections, injuries, and chronic conditions.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1680.20 Million |
| Market Size 2030 | USD 1907.91 Million |
| CAGR 2025-2030 | 2.10% |
| Fastest Growing Segment | Immunoturbidimetric Assays |
| Largest Market | North America |
Healthcare professionals frequently use CRP testing to diagnose and monitor a broad range of conditions, including infectious diseases, autoimmune disorders, cardiovascular ailments, and post-surgical complications. Test results, reported in milligrams per liter (mg/L), provide valuable insight into the severity and progression of inflammation, supporting timely diagnosis and disease management strategies.
Key Market Drivers
Increasing Prevalence of Inflammatory and Infectious Diseases
A primary factor fueling market expansion is the growing global burden of inflammatory and infectious diseases. CRP testing is a critical diagnostic and prognostic tool used to detect and monitor a wide spectrum of conditions, including infections, autoimmune diseases, and cardiovascular disorders. As the incidence of these conditions rises globally, the demand for reliable inflammatory biomarkers like CRP continues to grow.
CRP testing is particularly important in managing chronic inflammatory diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and lupus, as well as acute conditions like sepsis and pneumonia. It is estimated that 18 million individuals are affected by RA worldwide, with women comprising 70% of cases and over half of the affected population aged 55 or older. Notably, 13 million people suffer from moderate to severe RA, where early diagnosis and rehabilitation can significantly improve quality of life.
The rising prevalence of autoimmune and inflammatory conditions-driven by a combination of genetic, environmental, and lifestyle factors-has prompted broader adoption of CRP testing in routine clinical diagnostics.
Key Market Challenges
Lack of Specificity in Elevated CRP Levels
One of the key challenges limiting the market's full potential is the non-specific nature of elevated CRP levels. While CRP is a reliable marker of inflammation, it does not provide diagnostic specificity regarding the underlying cause. This ambiguity can complicate clinical decision-making, requiring additional tests to identify the root condition, thereby prolonging diagnosis and treatment initiation.
Furthermore, due to its generalized nature, CRP testing is sometimes ordered inappropriately or excessively, particularly in cases where inflammation may not be clinically significant. This can lead to unnecessary healthcare spending and inefficient utilization of resources, contributing to diagnostic overuse and potential overdiagnosis.
Key Market Trends
Growing Emphasis on Personalized Medicine
The increasing focus on personalized medicine represents a transformative trend shaping the CRP testing market. Personalized medicine seeks to tailor medical treatment based on individual patient profiles, including genetic characteristics, lifestyle, and biomarker data. CRP serves as a critical biomarker for inflammation, enabling healthcare providers to design more targeted and effective treatment plans.
CRP testing plays a pivotal role in risk assessment, particularly for cardiovascular diseases, where elevated CRP levels may signal higher risk and prompt preventive interventions tailored to an individual's needs. It also supports continuous disease monitoring, allowing clinicians to track inflammation over time and make informed adjustments to treatment regimens based on changing CRP values.
Key Market Players
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corp
- Quest Diagnostics
- Siemens Healthineers AG
- Abbott Laboratories Inc.
- Merck KGaAA
- Zoetis Inc.
- Ortho Clinical Diagnostics
- Getein Biotech, Inc.
Report Scope:
In this report, the Global C-reactive Protein Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
C-reactive Protein Testing Market, By Assay Type:
- Immunoturbidimetric Assay
- ELISA
- Chemiluminescence Immunoassay
- Others
C-reactive Protein Testing Market, By Detection Range:
- hs-CRP
- Conventional CRP
- cCRP
C-reactive Protein Testing Market, By Disease Area:
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
C-reactive Protein Testing Market, By End-User:
- Hospitals & Clinics
- Laboratories
- Assisted Living Healthcare Facilities
- Homecare
- Others
C-reactive Protein Testing Market, By region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global C-reactive Protein Testing Market.
Available Customizations:
Global C-reactive Protein Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. C-reactive Protein Testing Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others)
- 5.2.2. By Detection Range (hs-CRP, Conventional CRP, cCRP)
- 5.2.3. By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others)
- 5.2.4. By End-Use Industry (Hospitals & Clinics, Laboratories, Assisted Living Healthcare Facilities, Homecare, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2024)
- 5.3. Market Map
6. North America C-reactive Protein Testing Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Assay Type
- 6.2.2. By Detection Range
- 6.2.3. By Disease Are
- 6.2.4. By End-Use Industry
- 6.2.5. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States C-reactive Protein Testing Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Assay Type
- 6.3.1.2.2. By Detection Range
- 6.3.1.2.3. By Disease Are
- 6.3.1.2.4. By End-Use Industry
- 6.3.2. Canada C-reactive Protein Testing Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Assay Type
- 6.3.2.2.2. By Detection Range
- 6.3.2.2.3. By Disease Are
- 6.3.2.2.4. By End-Use Industry
- 6.3.3. Mexico C-reactive Protein Testing Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Assay Type
- 6.3.3.2.2. By Detection Range
- 6.3.3.2.3. By Disease Are
- 6.3.3.2.4. By End-Use Industry
7. Europe C-reactive Protein Testing Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Assay Type
- 7.2.2. By Detection Range
- 7.2.3. By Disease Are
- 7.2.4. By End-Use Industry
- 7.2.5. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany C-reactive Protein Testing Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Assay Type
- 7.3.1.2.2. By Detection Range
- 7.3.1.2.3. By Disease Are
- 7.3.1.2.4. By End-Use Industry
- 7.3.2. United Kingdom C-reactive Protein Testing Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Assay Type
- 7.3.2.2.2. By Detection Range
- 7.3.2.2.3. By Disease Are
- 7.3.2.2.4. By End-Use Industry
- 7.3.3. Italy C-reactive Protein Testing Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Assay Type
- 7.3.3.2.2. By Detection Range
- 7.3.3.2.3. By Disease Are
- 7.3.3.2.4. By End-Use Industry
- 7.3.4. France C-reactive Protein Testing Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Assay Type
- 7.3.4.2.2. By Detection Range
- 7.3.4.2.3. By Disease Are
- 7.3.4.2.4. By End-Use Industry
- 7.3.5. Spain C-reactive Protein Testing Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Assay Type
- 7.3.5.2.2. By Detection Range
- 7.3.5.2.3. By Disease Are
- 7.3.5.2.4. By End-Use Industry
8. Asia-Pacific C-reactive Protein Testing Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Assay Type
- 8.2.2. By Detection Range
- 8.2.3. By Disease Are
- 8.2.4. By End-Use Industry
- 8.2.5. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China C-reactive Protein Testing Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Assay Type
- 8.3.1.2.2. By Detection Range
- 8.3.1.2.3. By Disease Are
- 8.3.1.2.4. By End-Use Industry
- 8.3.2. India C-reactive Protein Testing Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Assay Type
- 8.3.2.2.2. By Detection Range
- 8.3.2.2.3. By Disease Are
- 8.3.2.2.4. By End-Use Industry
- 8.3.3. Japan C-reactive Protein Testing Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Assay Type
- 8.3.3.2.2. By Detection Range
- 8.3.3.2.3. By Disease Are
- 8.3.3.2.4. By End-Use Industry
- 8.3.4. South Korea C-reactive Protein Testing Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Assay Type
- 8.3.4.2.2. By Detection Range
- 8.3.4.2.3. By Disease Are
- 8.3.4.2.4. By End-Use Industry
- 8.3.5. Australia C-reactive Protein Testing Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Assay Type
- 8.3.5.2.2. By Detection Range
- 8.3.5.2.3. By Disease Are
- 8.3.5.2.4. By End-Use Industry
9. South America C-reactive Protein Testing Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Assay Type
- 9.2.2. By Detection Range
- 9.2.3. By Disease Are
- 9.2.4. By End-Use Industry
- 9.2.5. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil C-reactive Protein Testing Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Assay Type
- 9.3.1.2.2. By Detection Range
- 9.3.1.2.3. By Disease Are
- 9.3.1.2.4. By End-Use Industry
- 9.3.2. Argentina C-reactive Protein Testing Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Assay Type
- 9.3.2.2.2. By Detection Range
- 9.3.2.2.3. By Disease Are
- 9.3.2.2.4. By End-Use Industry
- 9.3.3. Colombia C-reactive Protein Testing Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Assay Type
- 9.3.3.2.2. By Detection Range
- 9.3.3.2.3. By Disease Are
- 9.3.3.2.4. By End-Use Industry
10. Middle East and Africa C-reactive Protein Testing Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Assay Type
- 10.2.2. By Detection Range
- 10.2.3. By Disease Are
- 10.2.4. By End-Use Industry
- 10.2.5. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa C-reactive Protein Testing Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Assay Type
- 10.3.1.2.2. By Detection Range
- 10.3.1.2.3. By Disease Are
- 10.3.1.2.4. By End-Use Industry
- 10.3.2. Saudi Arabia C-reactive Protein Testing Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Assay Type
- 10.3.2.2.2. By Detection Range
- 10.3.2.2.3. By Disease Are
- 10.3.2.2.4. By End-Use Industry
- 10.3.3. UAE C-reactive Protein Testing Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Assay Type
- 10.3.3.2.2. By Detection Range
- 10.3.3.2.3. By Disease Are
- 10.3.3.2.4. By End-Use Industry
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Developments
- 12.2. Product Launches
- 12.3. Mergers & Acquisitions
13. Global C-reactive Protein Testing Market: SWOT Analysis
14. Competitive Landscape
- 14.1. Thermo Fisher Scientific, Inc.
- 14.1.1. Business Overview
- 14.1.2. Product & Service Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (If Listed)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
- 14.2. F. Hoffmann-La Roche Ltd.
- 14.3. Danaher Corp
- 14.4. Quest Diagnostics
- 14.5. Siemens Healthineers AG
- 14.6. Abbott Laboratories Inc.
- 14.7. Merck KGaAA
- 14.8. Zoetis Inc.
- 14.9. Ortho Clinical Diagnostics
- 14.10.Getein Biotech, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
